A highly recurrent RPS27 5'UTR mutation in melanoma
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
// Ken Dutton-Regester 1,* , Jared J. Gartner 2,* , Rafi Emmanuel 3 , Nouar Qutob 3 , Michael A. Davies 4 , Jeffrey E. Gershenwald 4 , William Robinson 5 , Steven Robinson 5 , Steven A. Rosenberg 2 , Richard A. Scolyer 6,7,8 , Graham J. Mann 6,9 , John F. Thompson 6,10,11 , Nicholas K. Hayward 1 , Yardena Samuels 3 1 QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia 2 National Cancer Institute, NIH, MD, USA 3 Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel 4 The University of Texas MD Anderson Cancer Center, Houston, TX, USA 5 University of Colorado School of Medicine, Aurora, CO, USA 6 Melanoma Institute of Australia (formerly the Sydney Melanoma Unit), North Sydney,NSW, Australia 7 Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia 8 Discipline of Pathology, Sydney Medical School, The University of Sydney, NSW, Australia 9 University of Sydney at Westmead Millenium Institute, Westmead, NSW, Australia 10 Departments of Melanoma and Surgical Oncology, and Royal Prince Alfred Hospital, Sydney, New South Wales, Australia 11 Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia * These authors contributed equally to this work Correspondence: Yardena Samuels, email: // Nicholas K. Hayward, email: // Keywords : Melanoma, somatic mutation, RPS27, exome sequencing, 5’ untranslated region Received : April 8, 2014 Accepted : May 30, 2014 Published : June 1, 2014 Abstract The incidence of melanoma continues to rise globally and is increasing at a rate greater than any other cancer. To systematically search for new genes involved in melanomagenesis, we collated exome sequencing data from independent melanoma cohort datasets, including those in the public domain. We identified recurrent mutations that may drive melanoma growth, survival or metastasis, and which may hold promise for the design of novel therapies to treat melanoma. These included a frequent recurrent (i.e. hotspot) mutation in the 5’ untranslated region of RPS27 in ~10% of samples. We show that the mutation expands the 5’TOP element, a motif known to regulate the expression of most of the ribosomal protein family, to which RPS27 belongs, and thus might sensitize the mutated transcript to growth-mediated regulation. This finding highlights not only the important role of non-protein coding genetic aberrations in cancer development but also their potential as novel therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Discovery and saturation analysis of cancer genes across 21 tumour types
Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., Meyerson, M., Gabriel, S. B., Lander, E. S., & Getz, G. (2014) · Nature · doi:10.1038/nature12912 · Cited by 3,096
A landscape of driver mutations in melanoma
Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610
Self-citationA comprehensive catalogue of somatic mutations from a human cancer genome
Pleasance, E. D., Cheetham, R. K., Stephens, P. J., McBride, D. J., Humphray, S. J., Greenman, C. D., Varela, I., Lin, M.-L., Ordóñez, G. R., Bignell, G. R., et al. (2010) · Nature · doi:10.1038/nature08658 · Cited by 1,696
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
Krauthammer, M., Kong, Y., Ha, B. H., Evans, P., Bacchiocchi, A., McCusker, J. P., Cheng, E., Davis, M. J., Goh, G., Choi, M., et al. (2012) · Nature Genetics · doi:10.1038/ng.2359 · Cited by 1,191 · cited 2×
“As expected, this list included well documented frequent oncogenic drivers of melanoma, including hotspot mutations in BRAF, NRAS, RAC1, PPP6C, TRRAP, MAP3K5 and BCL2L12 [5, 17, 27-29].”
BackgroundSelf-citationMelanoma genome sequencing reveals frequent PREX2 mutations
Berger, M. F., Hodis, E., Heffernan, T. P., Deribe, Y. L., Lawrence, M. S., Protopopov, A., Ivanova, E., Watson, I. R., Nickerson, E., Ghosh, P., et al. (2012) · Nature · doi:10.1038/nature11071 · Cited by 756
Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4
Program, N. C. S., Prickett, T. D., Agrawal, N. S., Wei, X., Yates, K. E., Lin, J. C., Wunderlich, J. R., Cronin, J. C., Cruz, P., Rosenberg, S. A., et al. (2009) · Nature Genetics · doi:10.1038/ng.438 · Cited by 352
Self-citationmTOR Is Activated in the Majority of Malignant Melanomas
Karbowniczek, M., Spittle, C. S., Morrison, T., Wu, H., & Henske, E. P. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701074 · Cited by 168
Cited by
Genomic classification of cutaneous melanoma
Akbani, R., Akdemir, K. C., Aksoy, B. A., Albert, M., Ally, A., Amin, S. B., Arachchi, H., Arora, A., Auman, J. T., Ayala, B., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.044 · Cited by 3,151
“The recurrent mutation in RPS27 was recently shown to expand the 50 TOP element, a motif known to control mRNA translation regulated through the PI(3)K/AKT and mTOR pathways (Dutton-Regester et al., 2014).”
Self-citationWhole-genome landscapes of major melanoma subtypes
Hayward, N. K., Wilmott, J. S., Waddell, N., Johansson, P. A., Field, M. A., Nones, K., Patch, A.-M., Kakavand, H., Alexandrov, L. B., Burke, H., et al. (2017) · Nature · doi:10.1038/nature22071 · Cited by 1,461
Self-citationRibosomal proteins and human diseases: molecular mechanisms and targeted therapy
Kang, J., Brajanovski, N., Chan, K. T., Xuan, J., Pearson, R. B., & Sanij, E. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00728-8 · Cited by 408
How Ribosomes Translate Cancer
Sulima, S. O., Hofman, I. J. F., De Keersmaecker, K., & Dinman, J. D. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0550 · Cited by 173
“Additionally, RPS27 contains an identical mutation in its 5′ UTR in 10% of patients with melanoma (103).”
BackgroundRecurrent inactivating RASA2 mutations in melanoma
Arafeh, R., Qutob, N., Emmanuel, R., Keren-Paz, A., Madore, J., Elkahloun, A., Wilmott, J. S., Gartner, J. J., Di Pizio, A., Winograd-Katz, S., et al. (2015) · Nature Genetics · doi:10.1038/ng.3427 · Cited by 107
Self-citation
Metadata
- Authors
- Dutton-Regester, K., Gartner, J. J., Emmanuel, R., Qutob, N., Davies, M. A., Gershenwald, J. E., Robinson, W., Robinson, S., Rosenberg, S. A., Scolyer, R. A., Mann, G. J., Thompson, J. F., Hayward, N. K., & Samuels, Y.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2014-05-30
- Volume
- 5
- Issue
- 10
- Pages
- 2912-2917
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2100344946
- Cited by
- 52
- References
- 7
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A highly recurrent RPS27 5'UTR mutation in melanoma. https://app.cochat.ai/papers/10.18632/oncotarget.2048
- The paper
- Dutton-Regester, K., Gartner, J. J., Emmanuel, R., Qutob, N., Davies, M. A., Gershenwald, J. E., Robinson, W., Robinson, S., Rosenberg, S. A., Scolyer, R. A., Mann, G. J., Thompson, J. F., Hayward, N. K., & Samuels, Y. (2014). A highly recurrent RPS27 5'UTR mutation in melanoma. Oncotarget. https://doi.org/10.18632/oncotarget.2048
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.